• レポートコード:MRC23Q36090 • 出版社/出版日:QYResearch / 2023年3月 • レポート形態:英文、PDF、112ページ • 納品方法:Eメール(2-3日) • 産業分類:医薬品 |
Single User | ¥435,000 (USD2,900) | ▷ お問い合わせ |
Enterprise License | ¥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界の免疫サポート成分市場について調査・分析し、世界の免疫サポート成分市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(ビタミンC、ビタミンE、その他ビタミン、ベータグルカン、カロテノイド、フィトステロール、オメガ3脂肪酸)、用途別セグメント分析(栄養補助食品、食品&飲料、医薬品、飼料、ペットフード、パーソナルケア製品)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、DSM、BASF、Zhejiang NHU、Croda、CSPC Pharma、EPAX、Adisseo、Zhejiang Medicine、Raisio Group、Northeast Pharma、Shandong Luwei、Allied Biotech、Cargill、Anhui Tiger、Shandong Tianli、Kerry、Dohler、Kemin、Chenguang Biotech、FMC、Chr. Hansen、Excelvite、DDWなどが含まれています。世界の免疫サポート成分市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争の影響は、免疫サポート成分市場規模を推定する際に考慮しました。本レポートは、免疫サポート成分の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、免疫サポート成分に関するビジネス上の意思決定に役立てることを目的としています。 ・免疫サポート成分市場の概要 - 免疫サポート成分のタイプ別セグメント - 世界の免疫サポート成分市場規模:タイプ別分析(ビタミンC、ビタミンE、その他ビタミン、ベータグルカン、カロテノイド、フィトステロール、オメガ3脂肪酸) - 免疫サポート成分の用途別セグメント - 世界の免疫サポート成分市場規模:用途別分析(栄養補助食品、食品&飲料、医薬品、飼料、ペットフード、パーソナルケア製品) - 世界の免疫サポート成分市場規模予測(2018年-2029年) ・免疫サポート成分市場の成長トレンド - 免疫サポート成分の地域別市場規模(2018年-2029年) - 免疫サポート成分市場ダイナミクス - 免疫サポート成分の業界動向 - 免疫サポート成分市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M&A動向 ・タイプ別セグメント:ビタミンC、ビタミンE、その他ビタミン、ベータグルカン、カロテノイド、フィトステロール、オメガ3脂肪酸 - 世界の免疫サポート成分のタイプ別市場規模(2018年-2023年) - 世界の免疫サポート成分のタイプ別市場規模(2024年-2029年) ・用途別セグメント:栄養補助食品、食品&飲料、医薬品、飼料、ペットフード、パーソナルケア製品 - 世界の免疫サポート成分の用途別市場規模(2018年-2023年) - 世界の免疫サポート成分の用途別市場規模(2024年-2029年) ・免疫サポート成分の地域別市場規模 - 北米の免疫サポート成分市場規模(2018年-2029年) - アメリカの免疫サポート成分市場規模(2018年-2029年) - ヨーロッパの免疫サポート成分市場規模(2018年-2029年) - アジア太平洋の免疫サポート成分市場規模(2018年-2029年) - 中国の免疫サポート成分市場規模(2018年-2029年) - 日本の免疫サポート成分市場規模(2018年-2029年) - 韓国の免疫サポート成分市場規模(2018年-2029年) - インドの免疫サポート成分市場規模(2018年-2029年) - オーストラリアの免疫サポート成分市場規模(2018年-2029年) - 中南米の免疫サポート成分市場規模(2018年-2029年) - 中東・アフリカの免疫サポート成分市場規模(2018年-2029年) ・主要企業のプロファイル:企業情報、事業概要、売上、動向 DSM、BASF、Zhejiang NHU、Croda、CSPC Pharma、EPAX、Adisseo、Zhejiang Medicine、Raisio Group、Northeast Pharma、Shandong Luwei、Allied Biotech、Cargill、Anhui Tiger、Shandong Tianli、Kerry、Dohler、Kemin、Chenguang Biotech、FMC、Chr. Hansen、Excelvite、DDW ・アナリストの観点/結論 ・調査方法とデータソース |
As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.
Highlights
The global Immunity Support Ingredients market was valued at US$ 17190 million in 2022 and is anticipated to reach US$ 23170 million by 2029, witnessing a CAGR of 5.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
From the perspective of manufacturers, the main global players of support innovations are DSM, BASF, Cargill, Kerry, Kemin, Croda, Zhejiang NHU, Chr. Hansen, Shandong Luwei, CSPC Pharma, Allied Biotech, Zhengjiang Medicine, Dohler, etc. In 2019, the global top five players are DSM, BASF, Zhejiang NHU, Croda and CSPC Pharma, with 44.78% market share of revenue. Among them, DSM is the largest manufacturers of Immunity Support Ingredients.DSM occupied about 23% of the global Immunity Support Ingredients market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immunity Support Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunity Support Ingredients.
The Immunity Support Ingredients market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immunity Support Ingredients market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunity Support Ingredients companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
DSM
BASF
Zhejiang NHU
Croda
CSPC Pharma
EPAX
Adisseo
Zhejiang Medicine
Raisio Group
Northeast Pharma
Shandong Luwei
Allied Biotech
Cargill
Anhui Tiger
Shandong Tianli
Kerry
Dohler
Kemin
Chenguang Biotech
FMC
Chr. Hansen
Excelvite
DDW
Segment by Type
Vitamin C
Vitamin E
Other Vitamins
Beta Glucans
Carotenoids
Phytosterols
Omega-3 Fatty Acids
Segment by Application
Nutrition Supplements
Foods & Beverages
Pharmaceuticals
Feeds
Pet Foods
Personal Care Products
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunity Support Ingredients companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunity Support Ingredients Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vitamin C
1.2.3 Vitamin E
1.2.4 Other Vitamins
1.2.5 Beta Glucans
1.2.6 Carotenoids
1.2.7 Phytosterols
1.2.8 Omega-3 Fatty Acids
1.3 Market by Application
1.3.1 Global Immunity Support Ingredients Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Nutrition Supplements
1.3.3 Foods & Beverages
1.3.4 Pharmaceuticals
1.3.5 Feeds
1.3.6 Pet Foods
1.3.7 Personal Care Products
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunity Support Ingredients Market Perspective (2018-2029)
2.2 Immunity Support Ingredients Growth Trends by Region
2.2.1 Global Immunity Support Ingredients Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immunity Support Ingredients Historic Market Size by Region (2018-2023)
2.2.3 Immunity Support Ingredients Forecasted Market Size by Region (2024-2029)
2.3 Immunity Support Ingredients Market Dynamics
2.3.1 Immunity Support Ingredients Industry Trends
2.3.2 Immunity Support Ingredients Market Drivers
2.3.3 Immunity Support Ingredients Market Challenges
2.3.4 Immunity Support Ingredients Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunity Support Ingredients Players by Revenue
3.1.1 Global Top Immunity Support Ingredients Players by Revenue (2018-2023)
3.1.2 Global Immunity Support Ingredients Revenue Market Share by Players (2018-2023)
3.2 Global Immunity Support Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunity Support Ingredients Revenue
3.4 Global Immunity Support Ingredients Market Concentration Ratio
3.4.1 Global Immunity Support Ingredients Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunity Support Ingredients Revenue in 2022
3.5 Immunity Support Ingredients Key Players Head office and Area Served
3.6 Key Players Immunity Support Ingredients Product Solution and Service
3.7 Date of Enter into Immunity Support Ingredients Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunity Support Ingredients Breakdown Data by Type
4.1 Global Immunity Support Ingredients Historic Market Size by Type (2018-2023)
4.2 Global Immunity Support Ingredients Forecasted Market Size by Type (2024-2029)
5 Immunity Support Ingredients Breakdown Data by Application
5.1 Global Immunity Support Ingredients Historic Market Size by Application (2018-2023)
5.2 Global Immunity Support Ingredients Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immunity Support Ingredients Market Size (2018-2029)
6.2 North America Immunity Support Ingredients Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immunity Support Ingredients Market Size by Country (2018-2023)
6.4 North America Immunity Support Ingredients Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunity Support Ingredients Market Size (2018-2029)
7.2 Europe Immunity Support Ingredients Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immunity Support Ingredients Market Size by Country (2018-2023)
7.4 Europe Immunity Support Ingredients Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunity Support Ingredients Market Size (2018-2029)
8.2 Asia-Pacific Immunity Support Ingredients Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immunity Support Ingredients Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunity Support Ingredients Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunity Support Ingredients Market Size (2018-2029)
9.2 Latin America Immunity Support Ingredients Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immunity Support Ingredients Market Size by Country (2018-2023)
9.4 Latin America Immunity Support Ingredients Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunity Support Ingredients Market Size (2018-2029)
10.2 Middle East & Africa Immunity Support Ingredients Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immunity Support Ingredients Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunity Support Ingredients Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DSM
11.1.1 DSM Company Detail
11.1.2 DSM Business Overview
11.1.3 DSM Immunity Support Ingredients Introduction
11.1.4 DSM Revenue in Immunity Support Ingredients Business (2018-2023)
11.1.5 DSM Recent Development
11.2 BASF
11.2.1 BASF Company Detail
11.2.2 BASF Business Overview
11.2.3 BASF Immunity Support Ingredients Introduction
11.2.4 BASF Revenue in Immunity Support Ingredients Business (2018-2023)
11.2.5 BASF Recent Development
11.3 Zhejiang NHU
11.3.1 Zhejiang NHU Company Detail
11.3.2 Zhejiang NHU Business Overview
11.3.3 Zhejiang NHU Immunity Support Ingredients Introduction
11.3.4 Zhejiang NHU Revenue in Immunity Support Ingredients Business (2018-2023)
11.3.5 Zhejiang NHU Recent Development
11.4 Croda
11.4.1 Croda Company Detail
11.4.2 Croda Business Overview
11.4.3 Croda Immunity Support Ingredients Introduction
11.4.4 Croda Revenue in Immunity Support Ingredients Business (2018-2023)
11.4.5 Croda Recent Development
11.5 CSPC Pharma
11.5.1 CSPC Pharma Company Detail
11.5.2 CSPC Pharma Business Overview
11.5.3 CSPC Pharma Immunity Support Ingredients Introduction
11.5.4 CSPC Pharma Revenue in Immunity Support Ingredients Business (2018-2023)
11.5.5 CSPC Pharma Recent Development
11.6 EPAX
11.6.1 EPAX Company Detail
11.6.2 EPAX Business Overview
11.6.3 EPAX Immunity Support Ingredients Introduction
11.6.4 EPAX Revenue in Immunity Support Ingredients Business (2018-2023)
11.6.5 EPAX Recent Development
11.7 Adisseo
11.7.1 Adisseo Company Detail
11.7.2 Adisseo Business Overview
11.7.3 Adisseo Immunity Support Ingredients Introduction
11.7.4 Adisseo Revenue in Immunity Support Ingredients Business (2018-2023)
11.7.5 Adisseo Recent Development
11.8 Zhejiang Medicine
11.8.1 Zhejiang Medicine Company Detail
11.8.2 Zhejiang Medicine Business Overview
11.8.3 Zhejiang Medicine Immunity Support Ingredients Introduction
11.8.4 Zhejiang Medicine Revenue in Immunity Support Ingredients Business (2018-2023)
11.8.5 Zhejiang Medicine Recent Development
11.9 Raisio Group
11.9.1 Raisio Group Company Detail
11.9.2 Raisio Group Business Overview
11.9.3 Raisio Group Immunity Support Ingredients Introduction
11.9.4 Raisio Group Revenue in Immunity Support Ingredients Business (2018-2023)
11.9.5 Raisio Group Recent Development
11.10 Northeast Pharma
11.10.1 Northeast Pharma Company Detail
11.10.2 Northeast Pharma Business Overview
11.10.3 Northeast Pharma Immunity Support Ingredients Introduction
11.10.4 Northeast Pharma Revenue in Immunity Support Ingredients Business (2018-2023)
11.10.5 Northeast Pharma Recent Development
11.11 Shandong Luwei
11.11.1 Shandong Luwei Company Detail
11.11.2 Shandong Luwei Business Overview
11.11.3 Shandong Luwei Immunity Support Ingredients Introduction
11.11.4 Shandong Luwei Revenue in Immunity Support Ingredients Business (2018-2023)
11.11.5 Shandong Luwei Recent Development
11.12 Allied Biotech
11.12.1 Allied Biotech Company Detail
11.12.2 Allied Biotech Business Overview
11.12.3 Allied Biotech Immunity Support Ingredients Introduction
11.12.4 Allied Biotech Revenue in Immunity Support Ingredients Business (2018-2023)
11.12.5 Allied Biotech Recent Development
11.13 Cargill
11.13.1 Cargill Company Detail
11.13.2 Cargill Business Overview
11.13.3 Cargill Immunity Support Ingredients Introduction
11.13.4 Cargill Revenue in Immunity Support Ingredients Business (2018-2023)
11.13.5 Cargill Recent Development
11.14 Anhui Tiger
11.14.1 Anhui Tiger Company Detail
11.14.2 Anhui Tiger Business Overview
11.14.3 Anhui Tiger Immunity Support Ingredients Introduction
11.14.4 Anhui Tiger Revenue in Immunity Support Ingredients Business (2018-2023)
11.14.5 Anhui Tiger Recent Development
11.15 Shandong Tianli
11.15.1 Shandong Tianli Company Detail
11.15.2 Shandong Tianli Business Overview
11.15.3 Shandong Tianli Immunity Support Ingredients Introduction
11.15.4 Shandong Tianli Revenue in Immunity Support Ingredients Business (2018-2023)
11.15.5 Shandong Tianli Recent Development
11.16 Kerry
11.16.1 Kerry Company Detail
11.16.2 Kerry Business Overview
11.16.3 Kerry Immunity Support Ingredients Introduction
11.16.4 Kerry Revenue in Immunity Support Ingredients Business (2018-2023)
11.16.5 Kerry Recent Development
11.17 Dohler
11.17.1 Dohler Company Detail
11.17.2 Dohler Business Overview
11.17.3 Dohler Immunity Support Ingredients Introduction
11.17.4 Dohler Revenue in Immunity Support Ingredients Business (2018-2023)
11.17.5 Dohler Recent Development
11.18 Kemin
11.18.1 Kemin Company Detail
11.18.2 Kemin Business Overview
11.18.3 Kemin Immunity Support Ingredients Introduction
11.18.4 Kemin Revenue in Immunity Support Ingredients Business (2018-2023)
11.18.5 Kemin Recent Development
11.19 Chenguang Biotech
11.19.1 Chenguang Biotech Company Detail
11.19.2 Chenguang Biotech Business Overview
11.19.3 Chenguang Biotech Immunity Support Ingredients Introduction
11.19.4 Chenguang Biotech Revenue in Immunity Support Ingredients Business (2018-2023)
11.19.5 Chenguang Biotech Recent Development
11.20 FMC
11.20.1 FMC Company Detail
11.20.2 FMC Business Overview
11.20.3 FMC Immunity Support Ingredients Introduction
11.20.4 FMC Revenue in Immunity Support Ingredients Business (2018-2023)
11.20.5 FMC Recent Development
11.21 Chr. Hansen
11.21.1 Chr. Hansen Company Detail
11.21.2 Chr. Hansen Business Overview
11.21.3 Chr. Hansen Immunity Support Ingredients Introduction
11.21.4 Chr. Hansen Revenue in Immunity Support Ingredients Business (2018-2023)
11.21.5 Chr. Hansen Recent Development
11.22 Excelvite
11.22.1 Excelvite Company Detail
11.22.2 Excelvite Business Overview
11.22.3 Excelvite Immunity Support Ingredients Introduction
11.22.4 Excelvite Revenue in Immunity Support Ingredients Business (2018-2023)
11.22.5 Excelvite Recent Development
11.23 DDW
11.23.1 DDW Company Detail
11.23.2 DDW Business Overview
11.23.3 DDW Immunity Support Ingredients Introduction
11.23.4 DDW Revenue in Immunity Support Ingredients Business (2018-2023)
11.23.5 DDW Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details